Skip to main content

Table 1 Demographic and disease characteristics of the participants

From: The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study

Characteristics

All participants (n = 716)

Gout (n = 653)

Asymptomatic hyperuricemia (n = 63)

Male, n (%)

604 (84.4)

553 (84.7)

51 (81.0)

Age (years)

47.8 ± 16.0

48.3 ± 15.8

43.2 ± 17.9

Education level

 Primary education or below

85 (11.9)

75 (11.5)

10 (15.9)

 University or above

376 (52.5)

350 (53.6)

26 (41.3)

Weight (kg)

67.5 (15.0)

63.0 (15.0)

67.0 ± 11.3

BMI (kg/ m2)

24.2 (5.06)

23.4 (4.7)

24.1 ± 3.2

 Normal (18.5~24.9), n(%)

350 (48.9)

319 (48.9)

31 (49.2)

 Overweight (25.0~29.9), n(%)

217 (30.3)

199 (30.5)

18 (28.6)

 Obesity (30.0~34.9), n(%)

38 (5.3)

37 (5.7)

1 (1.6)

 Severe obesity (35.0~39.9), n(%)

6 (0.8)

6 (0.9)

0

Smoking (current), n (%)

171 (23.9)

153 (23.4)

18 (28.5)

Drinking (current), n (%)

348 (48.6)

322 (49.3)

26 (41.3)

Duration of hyperuricemia (years)

6.0 (2.0–12.0)

6.0 (2.0–12.0)

6.0 (2.0–11.0)

Treatment, n (%)

 UA lowering therapy

430 (60.0)

423 (64.8)

7 (11.1)

 No medication

248 (34.6)

198 (30.3)

50 (79.4)

  1. BMI body mass index, UA uric acid, Data within normal distribution were stated as mean ± S.D., and data who did not meet normal distribution were expressed as median (interquartile range)